Channing Capital Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-573,212
Closed -$9.89M 157
2023
Q2
$9.89M Buy
573,212
+3,000
+0.5% +$61.4K 0.3% 62
2023
Q1
$13.7M Sell
570,212
-362,195
-39% -$7.88M 0.44% 53
2022
Q4
$16.2M Buy
+932,407
New +$19.7M 0.51% 48

Other funds holding CYRX

Channing Capital Management's CYRX Position: Q3 2023 in Review

Channing Capital Management sold out of CryoPort (CYRX) in Q3 2023, closing a stake of 573,212 shares — an estimated $9.89M sold.

Channing Capital Management first reported a position in CYRX in Q4 2022 and held it in 3 quarters. The position peaked at $16.2M in Q4 2022. 158 funds tracked by Wall St. Rank hold CYRX as of Q3 2023.

  • Channing Capital Management reported no remaining CryoPort position as of Q3 2023 after selling out during the quarter.
  • Channing Capital Management sold 573,212 CryoPort shares in Q3 2023, an estimated $9.89M.
  • Channing Capital Management first reported a position in CryoPort in Q4 2022 and held it in 3 quarters.
  • Channing Capital Management's CryoPort position peaked at $16.2M in Q4 2022.
  • 158 funds tracked by Wall St. Rank held CryoPort as of Q3 2023.

Based on Channing Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.